TABLE 2

Health Status and ART of PHIVYAs and PHEUYAs

Total (N = 248)PHIV (N = 151)PHEU (N = 97)χ2 (df)aP
Self-reported health conditions, n (%)b
 Asthma or allergies115 (46)74 (49)41 (42)1.08 (1).299
 Arthritis13 (5)6 (4)7 (7)1.25 (1).263
 Diseases of the heart10 (4)7 (5)3 (3)0.38 (1).540
 Hepatitis4 (2)4 (3)0 (0)2.61 (1).106c
 Diabetes3 (1)3 (2)0 (0)1.95 (1).163c
 Cancer2 (1)2 (1)0 (0)1.30 (1).255c
 Inpatient medical care (past y)47 (19)33 (22)14 (14)2.12 (1).146
 No. d in hospital (past y), mean (SD); range2.42 (11.75); 1–1203.62 (14.89); 1–1200.57 (1.84); 1–10−1.64d.100
 Any nonpsychopharmocologic mental health services82 (33)63 (42)19 (20)13.07 (1)<.001
 Psychotropic mental health treatment30 (12)24 (16)6 (6)5.24 (1).022
 Drug or alcohol treatment4 (2)2 (1)2 (2)0.20 (1).653c
HIV disease status (N = 126)
 CD4+ <100 cells per mm3, n (%)b19 (15)
 CD4+ <200 cells per mm3, n (%)b26 (20)
 CD4+ >500 cells per mm3, n (%)b56 (44)
 CD4+ cells per mm3, mean (range)491.42 (2–1430)
 VL <50 copies per mL, n (%)b65 (52)
 VL <200 copies per mL, n (%)b80 (64)
 VL >1000 copies per mL, n (%)b40 (32)
 VL log copies per mL, mean (median) 2.41 (1.66)
ART regimens (N = 132), n (%)b
 Not prescribed ART8 (6)
 No. drug classes (N = 124)
  ≤283 (67)
  338 (31)
  43 (2)
 Most common drug class combinations
  NRTI + bPI26 (21)
  NRTI + NNRTI22 (18)
  NRTI + bPI + INSI21 (17)
  NRTI + bINSI and/or INSI16 (13)
  INSI-containing regimen62 (50)
  bPI-containing regimen72 (58)
 No. pills per d (N = 118)
  139 (33)
  210 (8)
  329 (25)
  ≥440 (34)
 Dosing regimen (N = 115)
  Once daily100 (87)
  Twice daily15 (13)
  • bINSI, boosted integrase strand transfer inhibitor; df, degrees of freedom; INSI, integrase strand transfer inhibitor; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; —, not applicable.

  • a Statistics shown are χ2 and df from χ2 tests (dichotomous variables).

  • b Percentages are based on those without missing data.

  • c Unreliable test statistic because of low N meeting criteria.

  • d z score from the Mann–Whitney test.